Journal
PLACENTA
Volume 95, Issue -, Pages 1-8Publisher
W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2020.04.006
Keywords
Placenta; Preeclampsia; IUGR; Angiogenic; Inflammatory; Disease; Proteoglycans
Funding
- University of Medicine Greifswald, Greifswald, Germany
- University of Campania Luigi Vanvitelli, Naples, Italy
- University of Campania Luigi Vanvitelli
Ask authors/readers for more resources
The placenta, a temporary organ that forms during pregnancy, is the largest fetal organ and the first to develop. It is recognized as an organ that plays a vital role as a metabolic and physical barrier in the fetoplacental unit; throughout fetal development it acts as the lungs, gut, kidneys, and liver of the fetus. When its two components, the fetal and the maternal one, successfully interact, pregnancy proceeds healthily. However, in some cases there may be pregnancy disorders, such as preeclampsia (PE) and gestational diabetes mellitus (GDM), which can lead to a different outcome for the mother and the newborn. In recent years, several studies have been conducted to try to understand how the expression of factors involved in the development of the placenta varies under pathological conditions compared with normal conditions. The purpose of this review is to summarize recent discoveries in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available